Accelerated Approval For Bluebird’s Skysona Gives Teeth To US FDA Data Questions
Two required confirmatory studies will bolster application that relied on historical controls for orphan neurodegenerative disease.
Two required confirmatory studies will bolster application that relied on historical controls for orphan neurodegenerative disease.